Osteoporosis

A new meta-analysis found no improvement in symptoms or in quality of life among more than 2000 participants treated for subclinical disease.

Try this short quiz on the first update to the Endocrine Society practice guideline on hirsutism since 2008.

A new study found statin use is associated with a decreased risk of osteoporosis, hip fracture, and vertebral fracture in stroke patients. 

A patient's genetic predisposition to low bone mineral density can increase their risk for osteoporotic fractures, according to a new genome-wide association study. 

Authors of a new study devised a new algorithm that can help physicians identify and manage diabetic patients at increased fracture risk. 

Will the new recommendations affect your approach to osteoporosis screening and treatment? Scroll through our quick slideshow to get all the highlights. 

A bisphosphonate drug holiday linked to a 20% rise in hip fractures in older women, according to a new study. 

Browse new research on: diabetes agents preferred in osteoporosis patients, an alternative to BMI, and interventions that work for pediatric obesity.

Our May list includes a new treatment for osteoporosis, predictors of thyroid cancer recurrence, and fast-acting vs conventional insulin for T1DM.

A small pilot study is the first to report on bone health in people with an at least 50-year history of type 1 diabetes.

Our November list includes an injectable male contraceptive, resveratrol treatment for PCOS, and novel gene associated with Addison disease.

At ENDO 2016, researchers presented their findings on potential ways to prevent bone mass loss and possibly improve bone health.

Osteoporosis is undertreated with only half of patients who qualify for a diagnosis receiving treatment. There are particular considerations for patients with rheumatologic illness.

Systemic bone loss can occur in psoriatic arthritis, but it doesn’t always show up using traditional scanning methods, new research finds.

Rheumatology Network examines common comorbidities in rheumatoid arthritis and their role in limiting mobility.

Repetitive intraarticular corticosteroid injections to the temporomandibular joint do not prevent progressive osseous deformation nor normalize mandibular growth in children with juvenile idiopathic arthritis.

The European League Against Rheumatism and the American College of Rheumatology have published treatment recommendations for polymyalgia rheumatic, the most common inflammatory musculoskeletal disease of older people.

Study shows that patients with psoriatic arthritis and cutaneous psoriasis could be good candidates for total hip replacement.

Research shows a possible biological basis between gout, tomatoes and other foods.

Stress on joints appears to have no effect on urate deposition.

Evidence-based medicine and patient input needed in prescribing bisphosphonates for osteoporosis.

Combo therapy alleviates osteoarthritis knee pain enough to resume disease modifying exercise therapy.

This is the latest sortie in the war between over- and under-treatment of osteoporosis.

New study results shed light on questions about the effect of combining drugs to treat osteoporosis and what happens after a switch from one drug to another.

Following the release of revised National Osteoporosis Foundation guidelines and of the World Health Organization’s fracture risk assessment tool, several pharmacological therapies have become available to help improve outcomes in patients with osteoporosis.

Persons in the United States report musculoskeletal conditions-including arthritis, back pain, osteoporosis, and injuries-more than any other health condition, according to the US Bone and Joint Decade.

Involving patients in decision making may help improve the quality of care.